CBA Florida Inc (PK:CBAI)

Business Focus: Healthcare Facilities & Services

Feb 11, 2020 04:00 pm ET
CBA Florida, Inc. Announces Intent to Call Shareholder Meeting, Proposes Approval of Plan of Liquidation and Dissolution
LAS VEGAS, NV / ACCESSWIRE / February 11, 2020 / CBA Florida, Inc. (www.cbafloridainc.com) (OTC PINK:CBAI) ("CBAI" or the "Company") today announced that its Board of Directors (the "Board") has approved a Plan of Liquidation and Dissolution of the Company (the "Plan of Dissolution" or the "Plan"), subject to shareholder approval. The Company presently intends to hold an annual meeting of its shareholders (the "Annual Meeting") in the second quarter of 2020 for purposes of the e
Aug 14, 2018 11:00 am ET
CBA Florida, Inc. Provides 2018 Second Quarter Update
LAS VEGAS, NV / ACCESSWIRE / August 14, 2018 / CBA Florida, Inc. (www.cbafloridainc.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced an update for the second quarter ended June 30, 2018.
May 17, 2018 05:00 pm ET
Cord Blood America, Inc. Announces Closing of Sale of Business
Pursuant to the terms of the Purchase Agreement, upon the closing of the transaction, the articles of incorporation of the Company were amended to change the name of the Company to "CBA, Inc."
May 15, 2018 03:25 pm ET
Cord Blood America, Inc. Announces Shareholder Approval of Sale of Business
LAS VEGAS, NV / ACCESSWIRE / May 15, 2018 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced that at a Special Meeting of Shareholders held on May 14, 2018 (the "Special Meeting"), its shareholders authorized the previously announced sale of substantially all of its assets related to California Cryobank Stem Cell Services LLC (dba "FamilyCord") pursuant to and on the terms set forth in the Asset Purchase Agreement, dated as of February 6, 2018 (the "Purchase Agreement"), by a
May 14, 2018 08:00 am ET
Cord Blood America, Inc. Reports 2018 First Quarter Results
LAS VEGAS, NV / ACCESSWIRE / May 14, 2018 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced financial results for the first quarter ended March 31, 2018. Given the agreement entered into with California Cryobank Stem Cell Services LLC (dba "FamilyCord") to sell substantially all of the Company's assets, the operating results associated with the assets being sold have been reclassified into discontinued operations and the assets and liabilities are reflected as held-for-sale.
Apr 25, 2018 04:00 pm ET
Cord Blood America, Inc. Adopts Tax Benefits Preservation Plan
LAS VEGAS, NV / ACCESSWIRE / April 25, 2018 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced that its Board of Directors has adopted a tax benefits preservation plan (the "Plan") designed to preserve CBAI's ability to utilize its net operating loss carryforwards and other tax attributes (collectively, "Tax Benefits").
Apr 02, 2018 08:00 am ET
Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2017
LAS VEGAS, NV / ACCESSWIRE / April 2, 2018 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced financial results for fiscal year 2017. Given the agreement entered into with California Cryobank Stem Cell Services LLC (dba "FamilyCord") to sell substantially all of the Company's assets for a purchase price of $15.5 million, the operating results associated with the assets being sold have been reclassified into discontinued operations and the assets and liabilities are reflected
Feb 07, 2018 08:30 am ET
Cord Blood America, Inc. Announces Agreement to Sell Substantially All of Its Assets to FamilyCord
LAS VEGAS, NV / ACCESSWIRE / February 7, 2018 / Cord Blood America, Inc. (OTC PINK: CBAI) ("CBAI" or the "Company") announced today that it has entered into an agreement with California Cryobank Stem Cell Services LLC (dba "FamilyCord") for the sale of substantially all of its assets to FamilyCord for a purchase price of $15.5 million.
Nov 13, 2017 08:00 am ET
Cord Blood America Reports 2017 Third Quarter Results
LAS VEGAS, NV / ACCESSWIRE / November 13, 2017 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced financial results for the third quarter ended September 30, 2017.